Send the following on WhatsApp
Continue to Chathttps://es.marketscreener.com/cotizacion/accion/SHANDONG-XINHUA-PHARMACEU-1412701/noticia/Shandong-Xinhua-Pharmaceutical-Company-Limited-aprueba-el-dividendo-complementario-para-el-ejercicio-44217069/?utm_source=whatsapp&utm_medium=social&utm_campaign=share